Secondary hyperparathyroidism (SHPT) is characterized by elevated levels of parathyroid hormone (PTH), parathyroid hyperplasia, calcium and phosphorus metabolism disorders, as well as clinical conditions such as renal bone disease and vascular calcification. The gene discussed is PTH; the disease is phosphorus metabolism disease.